247 related articles for article (PubMed ID: 30560549)
1. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
2. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.
VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ
Elife; 2020 Jun; 9():. PubMed ID: 32553107
[TBL] [Abstract][Full Text] [Related]
3. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.
Bhanvadia RR; VanOpstall C; Brechka H; Barashi NS; Gillard M; McAuley EM; Vasquez JM; Paner G; Chan WC; Andrade J; De Marzo AM; Han M; Szmulewitz RZ; Vander Griend DJ
Clin Cancer Res; 2018 Aug; 24(15):3668-3680. PubMed ID: 29716922
[No Abstract] [Full Text] [Related]
4. MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.
Whitlock NC; Trostel SY; Wilkinson S; Terrigino NT; Hennigan ST; Lake R; Carrabba NV; Atway R; Walton ED; Gryder BE; Capaldo BJ; Ye H; Sowalsky AG
Oncogene; 2020 Aug; 39(34):5663-5674. PubMed ID: 32681068
[TBL] [Abstract][Full Text] [Related]
5. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.
Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB
Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998
[TBL] [Abstract][Full Text] [Related]
6. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
[TBL] [Abstract][Full Text] [Related]
7. Newly developed MEIS inhibitor selectively blocks MEIS
Girgin B; Kocabaş F
Gene; 2023 Jun; 871():147425. PubMed ID: 37044182
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
Storebjerg TM; Høyer S; Kirkegaard P; Bro F; ; Ørntoft TF; Borre M; Sørensen KD
BJU Int; 2016 Oct; 118(4):646-53. PubMed ID: 26779768
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Interaction of
Sipeky C; Gao P; Zhang Q; Wang L; Ettala O; Talala KM; Tammela TLJ; Auvinen A; Wiklund F; Wei GH; Schleutker J
Clin Cancer Res; 2018 Dec; 24(24):6265-6276. PubMed ID: 30181389
[TBL] [Abstract][Full Text] [Related]
11. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
[TBL] [Abstract][Full Text] [Related]
12. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
[TBL] [Abstract][Full Text] [Related]
13. A calcineurin-Hoxb13 axis regulates growth mode of mammalian cardiomyocytes.
Nguyen NUN; Canseco DC; Xiao F; Nakada Y; Li S; Lam NT; Muralidhar SA; Savla JJ; Hill JA; Le V; Zidan KA; El-Feky HW; Wang Z; Ahmed MS; Hubbi ME; Menendez-Montes I; Moon J; Ali SR; Le V; Villalobos E; Mohamed MS; Elhelaly WM; Thet S; Anene-Nzelu CG; Tan WLW; Foo RS; Meng X; Kanchwala M; Xing C; Roy J; Cyert MS; Rothermel BA; Sadek HA
Nature; 2020 Jun; 582(7811):271-276. PubMed ID: 32499640
[TBL] [Abstract][Full Text] [Related]
14. HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer.
Lu X; Fong KW; Gritsina G; Wang F; Baca SC; Brea LT; Berchuck JE; Spisak S; Ross J; Morrissey C; Corey E; Chandel NS; Catalona WJ; Yang X; Freedman ML; Zhao JC; Yu J
Nat Genet; 2022 May; 54(5):670-683. PubMed ID: 35468964
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.
Breyer JP; Avritt TG; McReynolds KM; Dupont WD; Smith JR
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738
[TBL] [Abstract][Full Text] [Related]
16. Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy.
Weiner AB; Faisal FA; Davicioni E; Karnes RJ; Griend DJV; Lotan TL; Schaeffer EM
Eur Urol Oncol; 2021 Dec; 4(6):955-962. PubMed ID: 32540218
[TBL] [Abstract][Full Text] [Related]
17. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men.
Heise M; Jarzemski P; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Haus O
Pol J Pathol; 2019; 70(2):127-133. PubMed ID: 31556563
[TBL] [Abstract][Full Text] [Related]
18. Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.
FitzGerald LM; Raspin K; Marthick JR; Field MA; Malley RC; Thomson RJ; Blackburn NB; Banks A; Charlesworth JC; Donovan S; Dickinson JL
Sci Rep; 2017 Dec; 7(1):17778. PubMed ID: 29259341
[TBL] [Abstract][Full Text] [Related]
19. A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.
Lin X; Qu L; Chen Z; Xu C; Ye D; Shao Q; Wang X; Qi J; Chen Z; Zhou F; Wang M; Wang Z; He D; Wu D; Gao X; Yuan J; Wang G; Xu Y; Wang G; Dong P; Jiao Y; Yang J; Ou-Yang J; Jiang H; Zhu Y; Ren S; Zhang Z; Yin C; Wu Q; Zheng Y; Turner AR; Tao S; Na R; Ding Q; Lu D; Shi R; Sun J; Liu F; Zheng SL; Mo Z; Sun Y; Xu J
Prostate; 2013 Jan; 73(2):169-75. PubMed ID: 22718278
[TBL] [Abstract][Full Text] [Related]
20. G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis.
Huang H; Cai B
Tumour Biol; 2014 Feb; 35(2):1177-82. PubMed ID: 24026887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
